๐ฐ John Grabenstein News
Page 2 - John Grabenstein News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Grabenstein. Real-time updates on events, politics, business and more.
February 2, 2022
The arrival of a vaccine for younger children could help harried parents who have had to contend with quarantines and closures of pre-schools and daycare centers
February 2, 2022
The companies said they began submitting data for an emergency use authorisation even though they did not meet a key target in their clinical trials.
February 2, 2022
The companies said they began submitting data for an emergency use authorisation even though they did not meet a key target in their clinical trials.
January 12, 2022
The company is also testing hybrid combinations of vaccine to target multiple coronavirus forms, as well as larger doses.
January 12, 2022
The company is also testing hybrid combinations of vaccine to target multiple coronavirus forms, as well as larger doses.
January 12, 2022
The company is also testing hybrid combinations of vaccine to target multiple coronavirus forms, as well as larger doses.
December 1, 2021
New research about breakthrough coronavirus infections finds they may be less likely to spread because the vaccinated dont shed the virus as long.
October 8, 2021
Anticipation is building that younger children will soon be able to get vaccinated against COVID-19, a major milestone on the path out of the pandemic.ย
July 7, 2021
COVID-19s delta variant is highly contagious. Will vaccines work against it? TODAY 6 hrs ago Erika Edwards The delta variant now accounts for half of the COVID-19 cases in many areas of the U.S., President Joe Biden said Tuesday, urging unvaccinated Americans to get the COVID-19 shots as the U.S. faces a dramatic rise in the "hypertransmissible" variant of the coronavirus. His plea included reassurances about the strength of the COVID-19 vaccines available in the U.S. "Fully v...
June 11, 2021
The next generation Covid-19 vaccines seeking a slice of the market A new group of vaccine makers is hoping to challenge the Covid-19 shots that are already household names, sharpening competition in what is set to be the first ever jab market to encompass the entire global population. BioNTech/Pfizer and Moderna, the pandemicโs mRNA-based vaccine frontrunners, have already booked billions of dollars in revenue, which they are using to boost production, sign new contracts and entrench their p...